These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10459544)

  • 21. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
    Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synergistic effect of Tautomycetin on Cyclosporine A-mediated immunosuppression in a rodent islet allograft model.
    Wee YM; Choi MY; Kang CH; Kim YH; Kim JH; Lee SK; Yu SY; Kim SC; Han DJ
    Mol Med; 2010; 16(7-8):298-306. PubMed ID: 20440443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets.
    Ishizuka J; Gugliuzza KK; Wassmuth Z; Hsieh J; Sato K; Tsuchiya T; Townsend CM; Fish JC; Thompson JC
    Transplantation; 1993 Dec; 56(6):1486-90. PubMed ID: 7506454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for the development of posttransplantation diabetes mellitus in simultaneous pancreas and kidney recipients.
    Rangel EB; Melaragno CS; de Sá JR; Gonzalez AM; Linhares MM; Aguiar W; Pestana JO
    Transplant Proc; 2004 May; 36(4):982-3. PubMed ID: 15194341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.
    Sakr M; Hassanein T; Gavaler J; Abu-Elmagd K; Fung J; Gordon R; Starzl T; Van Thiel D
    Transplantation; 1992 Apr; 53(4):786-91. PubMed ID: 1373535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients.
    Venkiteswaran K; Sgoutas DS; Santanam N; Neylan JF
    Transpl Int; 2001 Dec; 14(6):405-10. PubMed ID: 11793038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.
    Sarkodee-Adoo C; Sotirescu D; Sensenbrenner L; Rapoport AP; Cottler-Fox M; Tricot G; Ruehle K; Meisenberg B
    Transfusion; 2003 Jan; 43(1):78-84. PubMed ID: 12519434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of alpha-lipoic acid in ameliorating Cyclosporine A-induced pancreatic injury in albino rats: A structural, ultrastructural, and morphometric study.
    Abd-Ellah HF; Abou-Zeid NR
    Ultrastruct Pathol; 2017; 41(2):196-208. PubMed ID: 28272982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
    van Duijnhoven EM; Christiaans MHL; Boots JMM; Nieman FHM; Wolffenbuttel BHR; van Hooff JP
    J Am Soc Nephrol; 2002 Jan; 13(1):213-220. PubMed ID: 11752040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process.
    Krook H; Wennberg L; Hagberg A; Song Z; Groth CG; Korsgren O
    Transplantation; 2002 Oct; 74(8):1084-9. PubMed ID: 12438951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells.
    Polastri L; Galbiati F; Bertuzzi F; Fiorina P; Nano R; Gregori S; Aldrighetti L; Pozza G; Secchi A; Adorini L; Davalli AM
    Acta Diabetol; 2002 Dec; 39(4):229-33. PubMed ID: 12486498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents.
    Pereira MJ; Palming J; Rizell M; Aureliano M; Carvalho E; Svensson MK; Eriksson JW
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1885-94. PubMed ID: 25004245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period.
    Havrdova T; Jedinakova T; Lipar K; Skibova J; Saudek F
    Transplant Proc; 2011 Nov; 43(9):3270-2. PubMed ID: 22099774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
    Swenson JM; Fricker FJ; Armitage JM
    J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.
    Angaswamy N; Tiriveedhi V; Banan B; Benshoff N; Chapman W; Mohanakumar T
    Transpl Immunol; 2013 Dec; 29(1-4):64-70. PubMed ID: 24036218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial.
    Steinmüller TM; Gräf KJ; Schleicher J; Leder K; Bechstein WO; Mueller AR; Dette K; Schulz E; Neuhaus P
    Transplantation; 1994 Sep; 58(6):669-74. PubMed ID: 7524203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMP-420, a small molecular inhibitor of TNF-α, prolongs islet allograft survival by induction of suppressor of cytokine signaling-1: synergistic effect with cyclosporin-A.
    Angaswamy N; Fukami N; Tiriveedhi V; Cianciolo GJ; Mohanakumar T
    Cell Transplant; 2012; 21(6):1285-96. PubMed ID: 22469483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.